Crossmark

Accounting for Pharmacokinetic Variability of Certolizumab Pegol in Patients with Crohn’s Disease

Crossref DOI link: https://doi.org/10.1007/s40262-017-0535-3

Published Online: 2017-03-28

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vande Casteele, Niels

Mould, Diane R.

Coarse, Jason

Hasan, Iram

Gils, Ann

Feagan, Brian

Sandborn, William J.
Funding

Funding for this research was provided by:

UCB Pharma
License Information

License valid from 2017-03-28